Dr. Catherine Legault serves as an Assistant Professor in the Department of Neurology and Neurosurgery at McGill University and Co-director of the Stroke Programme at the McGill University Health Centre. She is a neurologist at The Neuro (Montreal Neurological Institute-Hospital), a bilingual academic healthcare institution and part of McGill's Neuroscience Mission. Her educational background includes: Medical degree from McGill University (2011) Internship in Internal Medicine at Montreal’s Jewish General Hospital Neurology Residency at The Neuro (2012-2015) with chief residency (2014-2015) Vascular Neurology fellowship at Stanford University NIH StrokeNet fellowship Dr. Legault's clinical research focuses on translational stroke care, emphasizing acute interventions, rehabilitation innovation, and systems optimization. Her work integrates wearable technology with traditional stroke recovery methods while addressing post-stroke cognitive and visual impairments. She actively develops patient-centered educational frameworks and investigates hemodynamic interventions like induced hypertension. As principal investigator for multiple stroke clinical trials at The Neuro's Clinical Research Unit, she bridges bench-to-bedside research. Her teaching spans emergency consultations, bedside clinical supervision, and outpatient stroke clinics for residents and medical students. Through multidisciplinary collaboration in the Stroke Programme, Dr. Legault advances integrated care models that connect acute treatment with long-term rehabilitation, focusing on measurable functional outcomes and healthcare system efficiency.
Prof. Dr. Dennis Säring is a faculty member at the University of Applied Sciences Wedel , specifically affiliated with the School of Engineering. His academic and research activities focus on Deep Learning , Medical Image Analysis , and applications of Artificial Intelligence in healthcare and biomedical imaging. He has led seminars on Deep Learning topics and supervised student projects in Autonomous Driving at Audi's AADC 2018 competition. Research Highlights : Cardiovascular imaging, forensic age estimation via MRI, neural network-based bone segmentation, and cerebrovascular aneurysm analysis. Technical Expertise : Cardiac MRI, 3D/4D image processing, parametric mapping, and spatiotemporal data fusion. His recent publications (2018-2023) emphasize 3D MR segmentation for age assessment, CMR strain analysis in athletes, and T1/T2 mapping for myocarditis. Key collaborations include institutions like the University Medical Center Hamburg-Eppendorf and Wedler Hochschulbund, with funding for autonomous vehicle research. While no explicit scientific awards are listed, his work spans clinical cardiology, forensic radiology, and AI-driven medical diagnostics.
Andre Levchenko is the John C. Malone Professor of Biomedical Engineering at Yale University, with secondary appointments in the Department of Neurosurgery and affiliations with the Cancer Signaling Networks, Immunology, and the Yale Program in Neurodevelopment and Regeneration. His research focuses on systems biology, signal transduction, and cell-cell communication, utilizing microfluidics and computational modeling to study cancer progression, stem cell behavior, and neurological disorders. PhD, Columbia University MEng, Moscow Institute of Physics and Technology Levchenko's work explores how cells process dynamic signals to make critical decisions, particularly in glioblastoma migration, organoid development, and cardiovascular tissue engineering. His lab develops innovative microfluidic platforms and mathematical models to dissect multicellular communication and signaling networks. Recent publications highlight his contributions to understanding YAP-driven cancer invasion , NOTCH signaling in angiogenesis , and metabolic regulation of hypoxia responses . He has pioneered methods for organoid modeling and single-cell analysis , advancing precision in biological signaling studies. Scientific Awards : Computational Molecular Biology Post-Doctoral Fellowship (Burroughs Wellcome Fund) National Academies Keck Futures Conference Invitee Distinguished Guest Lecturer, University of Virginia American Asthma Foundation Early Excellence Award Fellow, American Institute for Medical and Biological Engineering Levchenko leads the Levchenko Lab at the Yale Systems Biology Institute, collaborating with institutions like Mayo Clinic and Yale Cancer Center. His research has received recognition in Faculty of 1000 and multiple journal highlights.
Dr. Birgit Frauscher is the Lincoln Financial Group Distinguished Professor in Neurobiology at Duke University School of Medicine, where she serves as Professor of Neurology and holds a secondary appointment in the Department of Biomedical Engineering at the Duke Pratt School of Engineering. She is currently the Director of the Duke Comprehensive Epilepsy Center and leads the Analytical Neurophysiology (ANPHY) Lab. Her clinical and research work focuses on epilepsy and sleep medicine, utilizing both invasive and non-invasive electrical recordings to study brain activity in humans. Dr. Frauscher completed her medical training, neurology residency, and subspecialty training in electroencephalography, epilepsy, and sleep medicine at the Medical University of Innsbruck in Austria. After completing her clinical training in 2008, she earned her habilitation degree in 2011. She further specialized in intracranial EEG and signal analysis during a visiting professorship at the Montreal Neurological Institute and Hospital, McGill University (2013-2015), where she later served as an Attending Epileptologist and Group Leader of Epilepsy. Her research interests focus on developing novel seizure-independent EEG markers for the epileptogenic zone, investigating sleep-epilepsy interactions, and using intracranial EEG to study brain physiology during wakefulness and sleep. Her work aims to improve epilepsy diagnosis, prognosis, and treatment outcomes by better localizing the epileptic focus. Dr. Frauscher's recent publications demonstrate her continued leadership in epilepsy research, with over 170 peer-reviewed papers and an H-index of 62. Dr. Frauscher has received several prestigious awards including the Clinician-Scientist awards of the FRSQ (2018-2023), the Michael Prize of the International League against Epilepsy (2019), and the Ernst Niedermeyer Prize from the Austrian Epilepsy Society (2015). Her scholarly work has significantly advanced clinical knowledge in epilepsy and sleep medicine, establishing her as a leading figure in the field. As Director of the Duke Comprehensive Epilepsy Center and head of the ANPHY lab, Dr. Frauscher oversees a research program dedicated to advancing neuroscience through innovative approaches to studying brain activity. Her lab employs quantifiable tools to investigate neurophysiological and pathological processes related to epilepsy and sleep, with the ultimate goal of improving patient outcomes through better understanding of brain function.
Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.
Swiss Federal Institute of Technology in LausanneSwitzerland
Mohamed Bouri is a Senior Lecturer and Researcher at École Polytechnique Fédérale de Lausanne (EPFL), where he is affiliated with the School of Engineering (STI) and specifically the Microengineering Department (SCI-STI-MB). He is part of the ReHAssist research group (http://rehassist.epfl.ch), which focuses on rehabilitation robotics and human-robot interaction. His office is located in the MED Building (MED 3 1016) at Station 9, 1015 Lausanne. Dr. Bouri's research spans several key areas in robotics and rehabilitation engineering. His primary focus is on the development and control of exoskeleton systems for mobility assistance and rehabilitation. He has made significant contributions to hip exoskeleton technology, adaptive control strategies, and human-robot interaction paradigms. His work bridges engineering principles with clinical applications, particularly for individuals with mobility impairments and neurological conditions. Additional research interests include sensory substitution techniques, balance control systems, and astronomical instrumentation involving robotic fiber positioners for multi-object spectrographs. Analysis of Dr. Bouri's recent publications reveals a strong emphasis on practical applications of robotics in rehabilitation settings. His work increasingly focuses on user-centered design, adaptive control systems that respond to individual user needs, and ecological validity in testing environments. There's a clear trend toward developing systems that can function effectively in real-world scenarios rather than controlled laboratory settings. His research also shows growing integration of physiological feedback mechanisms and multimodal sensing to enhance human-robot cooperation, with applications spanning from Parkinson's disease rehabilitation to astronomical instrumentation. Dr. Bouri has supervised numerous doctoral students whose theses reflect the breadth of his research interests, including work on lower-limb exoskeletons, robotic control systems, and rehabilitation technologies. His collaborative approach is evident in the extensive list of co-authored publications across multiple institutions and disciplines, demonstrating his ability to bridge engineering with clinical and astronomical applications. Based at EPFL's Microengineering Department, Dr. Bouri leads research activities within the ReHAssist laboratory, which specializes in rehabilitation assistance technologies. The lab focuses on developing innovative robotic solutions for mobility assistance, with particular expertise in exoskeleton design, control algorithms, and human-robot interaction paradigms. His work on projects like TWIICE One has demonstrated real-world impact in assistive technology development.
Zion Zibly, MD, MBA is an Associate Professor in the Department of Neurosurgery at Yale School of Medicine . He holds multiple leadership roles including Director of the Center of Neuromodulation , Director of the Center of Neurosurgical Cancer Pain , and Head of Stereotactic & Functional Neurosurgery and the Focused Ultrasound Institute . Previously served as Chair of Neurosurgery at Sheba Medical Center after graduating from Technion’s Faculty of Medicine (MD) and Coller School of Management (MBA). Research Interests: Specializes in Neuromodulation for movement disorders (Parkinson’s, tremors, dystonia), Deep Brain Stimulation , Gene Therapy for pediatric neurodegenerative conditions, Oncological Neurosurgery , and Neurological Pain Management . Combines Functional Neurosurgery with Focused Ultrasound technology. Scientific Contributions: Participated in pioneering Alzheimer’s brain stimulator procedures and Gene Therapy applications. Active member of the North American Association of Functional Neurosurgery and Israeli Neurosurgical Society . Clinical Expertise: Implantation of electrostimulators for Parkinson’s and essential tremor, treatment of Benign/Malignant CNS Tumors , and management of Neurological Pain Conditions . Affiliated with Yale Cancer Center and Center for Brain & Mind Health .
Daniel Razansky is a Full Professor at the Department of Information Technology and Electrical Engineering, ETH Zurich, leading the Professorship for Biomedical Imaging. His research spans engineering, physics, biology, and medicine, focusing on developing advanced in vivo imaging tools like optoacoustic tomography and ultrasound neuromodulation. His recent work emphasizes multi-scale functional and molecular imaging , with applications in neuroscience , Alzheimer’s disease , and stroke diagnostics . Collaborations include National Tsing Hua University and the EU Horizon consortium SWEEPICS. Current projects target hybrid imaging systems (e.g., MRI-MSOT) and image-guided neuromodulation. Scientific awards include the IPPA James Smith Prize for his contributions. His lab has secured significant grants, including a $2.5M NIH award and SNSF funding. He mentors PhD students like Quanyu Zhou and Eva Remlova, who have received accolades for their research. The Razansky Lab at ETH Zurich’s Preclinical Imaging Center explores medical microrobotics , dynamic fluid flow imaging , and neuroimaging techniques , aiming to bridge engineering with clinical applications.
Suradip Das is a Research Assistant Professor in the Department of Neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where he serves as a Senior Research Investigator. His work bridges neural engineering and regenerative medicine to address critical challenges in nerve and muscle repair. His academic training includes: B.Tech in Biotechnology from Heritage Institute of Technology (2010) PhD in Biosciences and Bioengineering from Indian Institute of Technology Guwahati (2016) Dr. Das specializes in biomaterials development , peripheral nerve injury models , neuromuscular interface engineering , and stem cell-based regeneration . His research pioneers innervated tissue-engineered muscle constructs, demonstrating how motor neurons and endothelial cells synergistically enhance skeletal myocyte maturation. He innovates custom mechanobioreactors that apply tensile forces to guide nanofiber alignment for optimal myofiber formation, significantly advancing volumetric muscle loss treatments. Analysis of his 15 most recent publications reveals a dominant focus on neuromuscular regeneration (75% of articles), with emerging exploration of psychedelic compounds in neural repair. His work consistently integrates human iPSC-derived models , multi-cellular co-cultures , and large-animal validation to address translational gaps. Key trends include optogenetic control of motor units (2023), porcine nerve injury models (2020), and the critical role of pre-innervation in creating pro-regenerative microenvironments (2020-2022). As a core member of the Cullen Lab, Dr. Das collaborates on developing biofabricated neural microtissues for delayed nerve fusion and rapid functional recovery. His research directly informs clinical strategies for peripheral nerve repair and muscle regeneration through rigorous mechanistic studies and innovative engineering solutions.
Maria T. Schultheis is a Professor in Drexel University's Department of Psychological and Brain Sciences and holds a joint appointment in the School of Biomedical Engineering, Science and Health Systems. As Interim Director of Clinical Training, she oversees clinical psychology education. She earned her PhD in Clinical Psychology from Drexel University in 1998. Her research focuses on neurorehabilitation, particularly applying virtual reality (VR) technology to assess and improve driving capacity and everyday functioning in individuals with neurological disorders like traumatic brain injury, stroke, and multiple sclerosis. She has pioneered VR-based driving simulators for clinical evaluation and rehabilitation. Her work integrates clinical psychology, engineering, and transportation science, addressing cognitive, physical, and behavioral demands of driving post-neurological injury. Key projects include developing driving assessment protocols for disabled populations and investigating fatigue management in MS patients. Her interdisciplinary approach has been funded by NIH, NIDRR, and the NMSS. Notable awards include the 2007 APA Early Career Award (Division 40) and recognition from the National Academy of Neuropsychology. Schultheis leads the Applied Neuro-Technologies Lab, emphasizing ecologically valid methodologies. Over 35 peer-reviewed publications and presentations at international forums highlight her contributions. She serves on the National Research Council’s Transportation Research Board, influencing policy on neurological disorders and mobility. Grants have supported projects like VR-based financial competency assessments and understanding dual-task demands in post-concussion driving. Her research also explores decision-making competency in young adults and the neurocognitive correlates of risky driving behaviors. Collaborations with biomedical engineers and transportation specialists reflect her commitment to bridging clinical practice and technological innovation for functional recovery.
Sylvia Richardson is an MRC Investigator at the MRC Biostatistics Unit and holds a Research Professorship at the University of Cambridge, where she served as Director of the Biostatistics Unit from 2012 to 2021. She is affiliated with the Cambridge Mathematics of Information in Healthcare Hub (CMIH) at the Centre for Mathematical Sciences. Her work bridges advanced statistical methodology with critical healthcare applications, particularly in the analysis of complex biomedical data. Richardson's research spans multiple domains of biostatistics with a strong emphasis on Bayesian approaches. Her work has significantly advanced spatial modeling and disease mapping techniques, developed sophisticated methods for handling measurement error in epidemiological studies, and pioneered mixture and clustering models for integrative analysis of heterogeneous data sources. Her research addresses fundamental challenges in analyzing longitudinal health data, multimorbidity patterns, and complex disease trajectories. Her publication record demonstrates consistent methodological innovation applied to pressing healthcare challenges. Recent work focuses on traumatic brain injury outcomes, multimorbidity progression, genomic analysis, and statistical approaches to pandemic data. The articles reveal a strong pattern of methodological development driven by real-world healthcare challenges, with particular attention to longitudinal analysis, Bayesian computation, and integrative modeling approaches that can handle diverse and complex data structures. While specific awards are not detailed in the available information, Richardson's leadership as Director of the MRC Biostatistics Unit for nearly a decade and her continued Research Professorship reflect significant recognition of her contributions to the field. Her work with major international consortia like CENTER-TBI demonstrates her role in large-scale collaborative research efforts addressing critical health challenges. Richardson's research has substantial implications for healthcare policy and practice, particularly in understanding disease progression, developing predictive models for patient outcomes, and creating methodological frameworks that can integrate diverse data sources to generate meaningful clinical insights. Her work continues to influence both statistical methodology and healthcare applications through ongoing research and leadership in the field.
Scott Michael Lindhorst, MD, is an Assistant Professor in the Department of Neurosurgery at the Medical University of South Carolina (MUSC) College of Medicine. He holds a dual appointment in the Division of Hematology/Medical Oncology within the Department of Medicine. Dr. Lindhorst specializes in neuro-oncology, focusing on central nervous system lymphomas, gliomas, and meningiomas, while also managing brain metastases through clinical trials. Education: BS in Microbiology from University of Florida (2001), MD from University of South Alabama College of Medicine (2005) Training: Residency in Internal Medicine, Fellowship in Hematology/Medical Oncology (University of Alabama at Birmingham), Fellowship in Neuro-Oncology (Duke University Medical Center) His research centers on immuno-oncology , glioblastoma therapy , and epigenetic cancer treatments , with a strong emphasis on clinical trials for novel therapies. Recent publications explore hypermutation in cancer , immune checkpoint inhibition , and programmed necrosis in glioblastoma . Dr. Lindhorst is board-certified in internal medicine, hematology, medical oncology, and neuro-oncology. Clinical practice includes CNS lymphomas , gliomas , meningiomas , and brain metastases , with dedicated clinical trials to advance treatment options.
Patrick J. Cahill, MD, is a pediatric spine specialist and the Robert M. Campbell Jr. Endowed Chair in Thoracic Insufficiency Syndrome at Children's Hospital of Philadelphia (CHOP). His clinical expertise spans disorders of the pediatric spine, scoliosis, cervical spine conditions, and minimally invasive surgical techniques. He leads the Center for Thoracic Insufficiency Syndrome, collaborating with pulmonology, anesthesia, and physical therapy teams. Academic Role: Physician Scientist Leadership: Director of the Center for Thoracic Insufficiency Syndrome Research Focus: Spinal growth modulation, 3D surgical planning, and reducing anesthesia exposure in young patients His work emphasizes fusionless treatments like magnetically expandable growing rods and Mehta casting, alongside innovations in dynamic MRI for preoperative assessment. Recent publications highlight comparative studies on spinal fusion techniques, surgical complication classifications, and multidisciplinary approaches to complex cases. Awards: Philadelphia Magazine's Top Doctors (2022), SRS Travelling Fellowship (2015) Professional Memberships: Scoliosis Research Society, North American Spine Society, Pediatric Orthopaedic Society of North America
Matthew B Potts, MD is an Associate Professor in the Department of Neurological Surgery at Northwestern University's Feinberg School of Medicine, with secondary appointments in Neurology (Ken and Ruth Davee Department) and Radiology. His clinical expertise spans cerebrovascular surgery, neurointerventional/endovascular procedures, and management of brain aneurysms, vascular malformations, stroke, and spinal vascular disease across multiple Northwestern Medicine hospitals including Shirley Ryan AbilityLab. Dr. Potts completed his BS at MIT (2000) and MD at UCSF (2007), followed by surgical internship (2008), neurological surgery residency (2013), and cerebrovascular fellowship at NYU (2015). BS: Massachusetts Institute of Technology (2000) MD: University of California, San Francisco (2007) Internship: University of California-San Francisco Medical Center, Surgery (2008) Residency: University of California-San Francisco Medical Center, Neurological Surgery (2013) Fellowship: New York University Medical Center, Endovascular/Cerebrovascular Surgery (2015) His research program centers on chronic subdural hematoma pathophysiology, emergency stroke thrombectomy process optimization, and aneurysm treatment outcomes. He employs clinical-translational approaches to improve cerebrovascular disease management through advanced surgical techniques and rigorous outcomes assessment. Recent 2025 publications reveal strong focus on hydrocephalus diagnostics, hematoma expansion biomarkers, vertebrobasilar anatomy, and dolichoectatic aneurysm natural history. These works demonstrate multidisciplinary collaboration across neurosurgery, neurology, and radiology to advance diagnostic precision and treatment efficacy in complex cerebrovascular disorders. Dr. Potts has received exceptional recognition for medical education, including three consecutive Outstanding Teacher Awards (2019-2021) and the John X. Thomas, Jr. Best Teachers Award (2020). His research contributions are honored by the NIH Rush L. Kirschstein Award (2012) and Howard Hughes Fellowship (2005). Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2021) Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2020) John X. Thomas, Jr. Best Teachers of Feinberg Award, Northwestern University Feinberg School of Medicine (2020) Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2019) Ivan Ciric Resident Teaching Award, Northwestern University Department of Neurological Surgery (2017) Best Scientific Presentation, UCSF Department of Neurological Surgery (2013) NIH Rush L. Kirschstein National Research Service Award, National Institutes of Health (2012) UCSF School of Medicine Alumni Scholarship Award, University of California, San Francisco (2006) Howard Hughes Medical Institute Medical Student Research Fellow, Howard Hughes Medical Institute (2005) UCSF Quarterly Research Fellowship, University of California, San Francisco (2005) MIT-Germany Program Research Fellowship, Massachusetts Institute of Technology (2001) As an educator, Dr. Potts mentors medical students and residents through Feinberg's neurological surgery program, evidenced by his resident teaching award. His research is supported by institutional resources and prior NIH funding, with current industry relationships including ownership in Rhaeos, Inc. He serves as Assistant Editor for Neurosurgery and Associate Editor for Operative Neurosurgery. He operates within Northwestern's integrated neurovascular team across multiple hospital sites, collaborating with neurologists, neuroradiologists, and rehabilitation specialists to deliver comprehensive care for complex cerebrovascular conditions, with ongoing work focused on improving health equity in stroke treatment and minimally invasive surgical innovation.
Frank E. Garcea, Ph.D., is a Research Assistant Professor in the Department of Neurosurgery and Neuroscience at the University of Rochester School of Medicine and Dentistry. His research focuses on the cognitive and neural mechanisms underlying tool use, apraxia, and stroke recovery. He employs neuropsychological testing, fMRI, and lesion-symptom mapping to study brain injury effects on functional connectivity and action knowledge. Education: Bachelor of Science in Psychology, St. John Fisher College (2006–2010) PhD in Brain and Cognitive Sciences, University of Rochester (2012–2017) Research Interests: Dr. Garcea investigates how brain regions like the parietal cortex and dorsal/ventral streams mediate object manipulation and tool use. His work explores stroke-related disconnection syndromes, motor speech coordination networks, and translational brain mapping to preserve neural function during surgery. He collaborates on projects involving epilepsy patients undergoing electrocorticography to study action-related neural pathways. Labs & Affiliations: Principal Investigator of the Garcea Lab at URMC, focusing on tool use deficits in brain tumor/stroke survivors. Affiliated with the Del Monte Institute for Neuroscience and the Neurobiology & Anatomy Program. His lab integrates neuroimaging, lesion analysis, and clinical care to advance personalized brain mapping strategies.
